These results indicated that the Gem plus Rom+Cis regimen was also effective in inhibiting proliferation and inducing death of T24 CDX tumour cells in vivo, and the ability of Gem plus Rom+Cis to control CDXs was not limited to one UC cell type. This evidence concerns the gene ROM1 and neoplasm.